Saturday 17 October 2026 Export VRTX’s income statement to Excel — free account

Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $12.0 billion, up 8.90% from fiscal 2024. In the quarter to June 2026, revenue grew 12.5%, EPS grew 7.96% and free cash flow grew 9.25%, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years.

499.39 9.36 −1.84%

Follow VRTX

Alert me

Market cap: $129.0B
P/E: 28.8×
Fwd P/E: 25.5×
Dividend yield: —
F-score: 8/9
Altman Z: 12.06
Beneish M: −2.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	23.54%	24.20%	22.54%	22.31%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	6	8	8	8
ROA Full definition →	17.12%	17.58%	16.41%	15.60%
ROIC Full definition →	24.09%	24.15%	21.63%	22.62%
Return on Tangible Assets Full definition →	42.89%	45.87%	44.62%	48.87%
Average Days of Receivables Full definition →	61.89	59.63	62.43	60.60
Free Cash Flow per Share Full definition →	14.96	14.60	12.49	13.06
Free Cash Flow Full definition →	3,796.10	3,710.30	3,193.80	3,337.20
Capital Expenditures Full definition →	(496.80)	(530.30)	(437.60)	(380.80)
Other line items
Cash ROIC Full definition →	13.51%	13.94%	12.64%	14.14%
Accounts Receivable Turnover Full definition →	6.25	6.43	6.55	6.34
Accounts Payable Turnover Full definition →	4.04	3.60	3.78	3.94
Inventory Turnover Full definition →	1.08	1.08	1.14	1.19
Average Days of Payables Full definition →	88.93	106.24	102.05	95.36
Days of Inventory on Hand Full definition →	365.48	383.59	372.85	369.11
Tax Rate Full definition →	(0.16)	(0.16)	(0.15)	(0.17)
Research and Development Expense of Revenue Full definition →	31.04%	31.85%	32.58%	33.56%
Selling, General and Administrative Expense of Revenue Full definition →	15.95%	15.14%	14.61%	14.02%
Share Based Compensation of Revenue Full definition →	5.47%	5.62%	5.72%	5.94%
Interest Coverage Full definition →	—	—	208.67	311.98
Operating CF/Net income Full definition →	0.97	0.98	0.92	1.01
Depreciation/Fixed assets Full definition →	0.13	0.14	0.14	0.14
Capex/Depreciation Full definition →	(2.24)	(2.44)	(2.09)	(1.90)
Revenue per Share Full definition →	49.61	48.08	46.94	45.87
Operating CF per Share Full definition →	16.92	16.69	14.20	14.55
Capex per Share Full definition →	(1.96)	(2.09)	(1.71)	(1.49)
Capex to Sales Full definition →	0.04	0.04	0.04	0.03

Show all line items

Columns are period end dates

Stockrow Weekly